ADRA2B Antikörper (Internal Region)
-
- Target Alle ADRA2B Antikörper anzeigen
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ADRA2B Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Affinity Chromatography
- Immunogen
- Synthesized peptide derived from the Internal region of human AR alpha2B.
- Isotyp
- IgG
- Top Product
- Discover our top product ADRA2B Primärantikörper
-
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) (AA 343-369) antibody
ADRA2B Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB22486 unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) antibodyADRA2B Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) (AA 349-378) antibodyADRA2B Reaktivität: Human WB, IF, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) (Intracellular) antibodyADRA2B Reaktivität: Ratte WB, IHC Wirt: Maus Monoclonal 5G10 unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) (AA 343-369) antibodyADRA2B Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) antibodyADRA2B Reaktivität: Human ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) antibodyADRA2B Reaktivität: Human, Ratte, Maus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) (AA 1-100) antibodyADRA2B Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) antibodyADRA2B Reaktivität: Ratte, Maus WB, IHC Wirt: Maus Monoclonal unconjugated
anti-Adrenergic, alpha-2B-, Receptor (ADRA2B) (2nd Extracellular Loop), (AA 160-174), (Cys169) antibodyADRA2B Reaktivität: Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
- Andere Bezeichnung
- ADRA2B (ADRA2B Produkte)
- Synonyme
- ADRA2L1 antikoerper, ADRA2RL1 antikoerper, ADRARL1 antikoerper, ALPHA2BAR antikoerper, alpha-2BAR antikoerper, Adra-2b antikoerper, [a]2B antikoerper, alpha2-C2 antikoerper, alpha2B antikoerper, ADRA2B antikoerper, zgc:194747 antikoerper, Adra2b antikoerper, adrenoceptor alpha 2B antikoerper, adrenergic receptor, alpha 2b antikoerper, adrenergic, alpha-2B-, receptor antikoerper, adrenoceptor alpha 2C antikoerper, ADRA2B antikoerper, Adra2b antikoerper, ADRA2C antikoerper, adra2b antikoerper
- Gen-ID
- 151
- UniProt
- P18089
- Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
-
